The impairment of stress sensitivity in these mice was recovered by treatment with the selective serotonin reuptake inhibitor (SSRI), fluvoxamine [152], suggesting that the serotonergic system is downstream of the Shati/Nat8l pathway in depression pathogenesis. Here, ASPNAT is linked to depressive symptom measurement.